Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A.

J Infect Dis. 2003 Jul 15;188(2):327-38. Epub 2003 Jul 9.

PMID:
12854090
2.

Strategies for the prevention of cervical cancer by human papillomavirus vaccination.

Williamson AL, Passmore JA, Rybicki EP.

Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):531-44. Epub 2005 Apr 12. Review.

PMID:
16150392
3.

Papillomavirus-like particle based vaccines: cervical cancer and beyond.

Schiller JT, Lowy DR.

Expert Opin Biol Ther. 2001 Jul;1(4):571-81. Review.

PMID:
11727495
4.

Chapter 16: Prophylactic human papillomavirus vaccines.

Lowy DR, Frazer IH.

J Natl Cancer Inst Monogr. 2003;(31):111-6. Review.

PMID:
12807954
5.

[Human papillomavirus prophylactic vaccines: stakes and perspectives].

Hantz S, Alain S, Denis F.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. Epub 2006 Jun 27. Review. French.

PMID:
16807045
6.

Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.

Ault KA.

Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S26-31. Review.

PMID:
16729901
7.

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.

Stanley MA.

Expert Rev Vaccines. 2003 Jun;2(3):381-9. Review.

PMID:
12903803
8.

Human papillomavirus vaccines.

Breitburd F, Coursaget P.

Semin Cancer Biol. 1999 Dec;9(6):431-44. Review.

PMID:
10712890
9.

Papillomavirus-like particles and HPV vaccine development.

Schiller JT, Lowy DR.

Semin Cancer Biol. 1996 Dec;7(6):373-82. Review.

PMID:
9284529
10.

Long-term efficacy of human papillomavirus vaccination.

Ault KA.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S27-30. Review.

PMID:
17938016
11.

Prospects for a vaccine against human papillomavirus.

Hines JF, Ghim S, Schlegel R, Jenson AB.

Obstet Gynecol. 1995 Nov;86(5):860-6. Review.

PMID:
7566866
12.

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

Stanley M, Lowy DR, Frazer I.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. Epub 2006 Jun 23. Review.

PMID:
16949996
13.

Preventative and therapeutic vaccines for cervical cancer.

Roden R, Wu TC.

Expert Rev Vaccines. 2003 Aug;2(4):495-516. Review.

PMID:
14711335
14.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
15.

Human papillomavirus vaccines.

Stanley MA.

Rev Med Virol. 2006 May-Jun;16(3):139-49. Review.

PMID:
16710836
16.
17.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
18.

[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice].

Lehtinen M, Malm C, Apter D, Heikkilä R, Heino P, Rimpilä K, Zilliacus R, Paavonen J.

Lakartidningen. 2003 Oct 23;100(43):3408-12. Review. Swedish.

PMID:
14626768
19.

Human papillomavirus vaccines.

Stanley MA.

Curr Opin Mol Ther. 2002 Feb;4(1):15-22. Review.

PMID:
11883690
20.

Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine.

Jochmus I, Schäfer K, Faath S, Müller M, Gissmann L.

Arch Med Res. 1999 Jul-Aug;30(4):269-74. Review.

PMID:
10573627

Supplemental Content

Support Center